EUVIMEDEUVIMED entdecken
Crossref

Nanostructured High-Entropy Yolk–Shell Oxides Platform for Efficient Metabolic Profiling of Diabetic Retinopathy

Ting Zhang, Yuxiang Hu, Heyuhan Zhang, Xiaorong Wu, Fangying Shi iD, Chunhui Deng iD

Analytical Chemistry · 2026

DOI: 10.1021/acs.analchem.6c00496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Ting Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Institutes of …. Hauptthemen laut MEDLINE: Metabolomics, Diabetic Retinopathy, Nanostructures, Oxides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is a leading cause of blindness in middle-aged and elderly populations worldwide, and its diagnosis remains challenging due to the reliance on subjective interpretation of retinal images by experienced ophthalmologists. Here, we report a nanoenabled metabolomics strategy based on laser desorption/ionization mass spectrometry (LDI MS) for accurate DR discrimination. High-entropy yolk-shell metal oxides were rationally designed as a novel inorganic LDI matrix. Owing to the pronounced lattice distortion and multicomponent "cocktail" effect, these high-entropy oxides exhibit enhanced light-matter interaction, efficient energy transfer, and superior desorption/ionization behavior compared with conventional trimetallic oxides. Leveraging this matrix, high-quality serum metabolic fingerprints were obtained from DR patients and healthy controls. Machine learning analysis using a Random Forest model achieved an area under the curve (AUC) exceeding 0.99 for group discrimination. Notably, a compact DR differentiation panel composed of five key metabolites (DR-D5) retained diagnostic performance comparable to the full fingerprint model, delivering an accuracy above 93%. Subsequent pathway analysis revealed metabolic perturbations associated with DR pathogenesis. This work establishes an integrated workflow encompassing nanostructured matrix design, high-performance metabolite detection, and data-driven modeling, offering a high-throughput and precise metabolomics platform with strong potential for noninvasive clinical screening of diabetic retinopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsDiabetic RetinopathyNanostructuresOxidesEntropyHumansSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationMachine Learning

Substanzen

Oxides

Autor:innen und Institutionen

  • Department of Chemistry, Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Institutes of Biomedical Sciences, Fudan University, Shanghai 201399, China.
  • Department of Ophthalmology, First Affiliated Hospital of Nanchang University, 17 Yongwai Street, Donghu District, Nanchang, Jiangxi 330006, China.
  • School of Materials Science and Chemical Engineering, Ningbo University, Ningbo 315211, China.
  • Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Department of Chemistry, Institutes of Biomedical Sciences, Fudan University, Shanghai 201399, China.

ORCID-Profile: Fangying Shi, Chunhui Deng

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, T., Hu, Y., Zhang, H., Wu, X., Shi, F., & Deng, C. (2026). Nanostructured High-Entropy Yolk–Shell Oxides Platform for Efficient Metabolic Profiling of Diabetic Retinopathy. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c00496

Vancouver

Zhang T, Hu Y, Zhang H, Wu X, Shi F, Deng C. Nanostructured High-Entropy Yolk–Shell Oxides Platform for Efficient Metabolic Profiling of Diabetic Retinopathy. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c00496

BibTeX
@article{Zhang2026,
  author = {Zhang, Ting and Hu, Yuxiang and Zhang, Heyuhan and Wu, Xiaorong and Shi, Fangying and Deng, Chunhui},
  title = {Nanostructured High-Entropy Yolk–Shell Oxides Platform for Efficient Metabolic Profiling of Diabetic Retinopathy},
  journal = {Analytical Chemistry},
  year = {2026},
  doi = {10.1021/acs.analchem.6c00496}
}
Kostenlos starten →